Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

STAAR Visian Toric ICL Post-Approval Study

← catalyst calendar

NCT04516772 · results posted

Sponsored by Staar Surgical Company (industry) · STAA — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Na · None · Treatment
Enrollment
125actual
Sites
8
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-27

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2020-07-21actualWhen the study began enrolling
Primary completion2024-12-11actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2024-12-11actualThe whole study's end, after follow-up
First posted2020-08-18actualWhen this record first appeared on the registry
Results posted2026-03-13actualWhen the sponsor posted results to the registry
Record updated2026-03-13actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Myopic Astigmatism

Intervention

  • Device: Visian TICL — also filed as Visian Toric ICL, TMICL

Primary outcome

what the primary-completion date above is the date OF
Change in Axis Orientation of the TICL
measured 18 to 24 months postoperative

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol and Statistical Analysis Planposted 2019-06-10 · 883 KB · Prot_SAP_000.pdf

Related

STAA · their whole pipeline

STAA's other studiesmost recently updated first

Permalink · STAA's whole pipeline · Catalyst calendar · Every registered study · What changed